ArticleAnnals of hematology2025

Combination therapy based on venetoclax overcomes resistance to all-trans retinoic acid and arsenic trioxide in a variant acute promyelocytic leukemia with TNRC18::RARA fusion.

Wenjing Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.